Takeda Ventures

Summary

In 2001 was created Takeda Ventures, which is appeared as VC. The main office of represented VC is situated in the Palo Alto. The fund was located in North America if to be more exact in United States. Takeda Ventures seemed to be an CVC arrangement as part of the organization.

We also calculated 6 valuable employees in our database.

Among the most popular fund investment industries, there are Pharmaceutical, Health Care. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Obsidian Therapeutics, Juventas Therapeutics, BIOMx Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager.

The fund is generally included in 2-6 deals every year. Comparing to the other companies, this Takeda Ventures performs on 13 percentage points less the average number of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2017. The increased amount of exits for fund were in 2019. Speaking about the real fund results, this VC is 2 percentage points more often commits exit comparing to other organizations. The typical startup value when the investment from Takeda Ventures is 5-10 millions dollars.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Takeda Ventures, startups are often financed by Sofinnova Partners, Forbion Capital Partners, Novo Holdings. The meaningful sponsors for the fund in investment in the same round are Sofinnova Partners, Boehringer Ingelheim Venture Fund, SR One. In the next rounds fund is usually obtained by Sofinnova Partners, Savitr Capital, Providence Investment Company Limited.